Clinical Trial Update: Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating fenofibrate for patients with primary biliary cirrhosis who had an inadequate response to ursodeoxycholic acid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: UNKNOWN